Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention

INTRODUCTION: Tamoxifen and raloxifene are chemopreventive drugs that can reduce women's relative risk of primary breast cancer by 50%; however, most women eligible for these drugs have chosen not to take them. The reasons for low uptake may be related to women's knowledge or attitudes tow...

Descripción completa

Detalles Bibliográficos
Autores principales: Korfage, Ida J, Fuhrel-Forbis, Andrea, Ubel, Peter A, Zikmund-Fisher, Brian J, Greene, Sarah M, McClure, Jennifer B, Smith, Dylan M, Hensley Alford, Sharon, Fagerlin, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978729/
https://www.ncbi.nlm.nih.gov/pubmed/24004815
http://dx.doi.org/10.1186/bcr3468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978729/
https://www.ncbi.nlm.nih.gov/pubmed/24004815
http://dx.doi.org/10.1186/bcr3468

Ejemplares similares